SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial. A Phase… Continue reading D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
Tag: M and A
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
ROCKVILLE, Md. and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, announced that AstraZeneca has agreed to acquire AbelZeta’s 50% share of the China development and commercialization rights to C-CAR031, such that AstraZeneca acquires the… Continue reading AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences, Inc. (Nasdaq: SPRB) (“Spruce”). Following… Continue reading Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
German FAZ: There is no such thing as a gentle conversion010454
From the rolling hills of Tuscany, some of the difficulties in faraway Germany may seem a little less sharp. But there are tasks that have to be completed, and Wolfgang Reitzle doesn’t want to let anything slide in the last few meters of his professional life. The 76-year-old captain of industry has created a retirement… Continue reading German FAZ: There is no such thing as a gentle conversion010454
Class Action Announcement BBWI: A Securities Fraud Class Action Lawsuit Was Filed Against Bath & Body Works, Inc. (BBWI)
Were you affected by investment losses in BBWI securities between June 4, 2024, and November 19, 2025? Affected Investor Losses Summary Bath & Body Works, Inc. securities fraud class action filed Purchasers or acquirers of Bath & Body Works, Inc. (NYSE: BBWI) securities Seeking recovery of investment losses for material misstatements and/or omissions (as alleged)… Continue reading Class Action Announcement BBWI: A Securities Fraud Class Action Lawsuit Was Filed Against Bath & Body Works, Inc. (BBWI)
JYD Deadline: JYD Investors with Losses in Excess of $100K Have Opportunity to Lead Jayud Global Logistics Ltd. Securities Fraud Lawsuit
NEW YORK, Jan. 18, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, both dates inclusive (the “Class Period”), of the important January 20, 2026 lead plaintiff deadline. So what: If you purchased… Continue reading JYD Deadline: JYD Investors with Losses in Excess of $100K Have Opportunity to Lead Jayud Global Logistics Ltd. Securities Fraud Lawsuit
Bronstein, Gewirtz & Grossman LLC Urges Smart Digital Group Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Jan. 18, 2026 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Smart Digital Group Ltd. (NASDAQ: SDM) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws… Continue reading Bronstein, Gewirtz & Grossman LLC Urges Smart Digital Group Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Jan. 18, 2026 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws… Continue reading Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Smart Digital Group Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Jan. 18, 2026 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Smart Digital Group Ltd. (NASDAQ: SDM) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws… Continue reading Bronstein, Gewirtz & Grossman LLC Urges Smart Digital Group Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
The Workers Building Labubus Are Allegedly Being Horribly Exploited
Edward Berthelot/Getty Images You know those small, gremlin-like plushies called Labubus that have taken over the globe by storm, launching a Beanie Baby-esque secondary market with soaring prices? While “blind boxes” — where buyers aren’t clued in to which one they’re getting — can go for as little as $20, more sought-after models are selling… Continue reading The Workers Building Labubus Are Allegedly Being Horribly Exploited